Ruxolitinib Side Effects
Some side effects of ruxolitinib may not be reported. Always consult your doctor or healthcare specialist for medical advice. You may also report side effects to the FDA.
For the Consumer
Applies to ruxolitinib: oral tablet
Get emergency medical help if you have any of these signs of an allergic reaction while taking ruxolitinib: hives; difficult breathing; swelling of your face, lips, tongue, or throat.
Some side effects may be similar to the symptoms of myelofibrosis. Call your doctor at once if you have a serious side effect such as:
-
pale skin, feeling light-headed or short of breath, rapid heart rate, trouble concentrating;
-
easy bruising, unusual bleeding (nose, mouth, vagina, or rectum), purple or red pinpoint spots under your skin;
-
fever, chills, body aches, flu symptoms, vomiting, sores in your mouth and throat;
-
pain or burning when you urinate; or
-
blisters or painful skin rash.
Less serious side effects of ruxolitinib may include:
-
headache;
-
dizziness;
-
weight gain; or
-
bloating gas.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects.
For Healthcare Professionals
Applies to ruxolitinib: oral tablet
Dermatologic
Dermatologic side effects have included bruising (23.2%).
Gastrointestinal
Gastrointestinal side effects have included flatulence (5.2%).
Genitourinary
Genitourinary side effects have included urinary tract infections (9.0%).
Hematologic
Hematologic side effects have included anemia (96.1%), thrombocytopenia (69.7%), and neutropenia (18.7%).
Immunologic
Immunologic side effects have included herpes zoster (1.9%).
Metabolic
Metabolic side effects have included weight gain (7.1%).
Laboratory abnormalities have included alanine transaminase (ALT) abnormalities (25.2%), aspartate transaminase (AST) abnormalities (17.4%), and elevated cholesterol levels (16.8%).
Nervous system
Nervous system side effects have included dizziness (18.1%), and headache (14.8%).
More ruxolitinib resources
- ruxolitinib MedFacts Consumer Leaflet (Wolters Kluwer)
- ruxolitinib Advanced Consumer (Micromedex) - Includes Dosage Information
- Ruxolitinib Professional Patient Advice (Wolters Kluwer)
- Jakafi Prescribing Information (FDA)
- Jakafi Monograph (AHFS DI)
- Jakafi Consumer Overview
Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of information provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.


